My Size, Inc.
For the period ended Dec 31, 2025. Filed Apr 15, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Apr 15, 2026
MYSZ$0.69-5.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
U.S. dollars in thousands
| Year ended December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash flows from operating activities: | ||
| Net loss | (5,852) | (3,995) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation | 18 | 20 |
| Loss on Disposal of property and equipment | - | 29 |
| Change in operating lease right-of-use asset | 17 | 147 |
| Amortization of intangible assets | 324 | 294 |
| Change in liabilities to related parties | (58) | (442) |
| Interest on long term liabilities | - | 47 |
| Interest paid | (7) | (41) |
| Revaluation of investment in marketable securities | 5 | (1) |
| Stock based compensation | 517 | 390 |
| Change in inventory | (142) | 112 |
| Impairment of goodwill | 144 | 631 |
| Change in account receivables | (828) | 335 |
| Change in operating lease liabilities | (12) | (96) |
| Chane in other non-current assets | (10) | - |
| Change in other receivables and prepaid expenses | 187 | (268) |
| Change in trade payables | 82 | (65) |
| Change in other payables | 623 | (189) |
| Change in Seller Payable | (150) | - |
| Net cash used in operating activities | (5,142) | (3,092) |
| Cash flows from investing activities: | ||
| Proceeds from short term deposits | 7 | 22 |
| Purchase of Percentil | (45) | - |
| Purchase of Shoe size me | (142) | - |
| Proceeds from liquidating JV | - | 38 |
| Purchase of property and equipment | (16) | (7) |
| Net cash (used in) provided by investing activities | (196) | 53 |
| Cash flows from financing activities: | ||
| Proceeds from issuance of shares, net of issuance costs and exercise of warrants | 3,130 | 5,829 |
| Loans received | - | 500 |
| Repayment of loans | (135) | (735) |
| Net cash provided by financing activities | 2,995 | 5,594 |
| Effect of exchange rate fluctuations on cash and cash equivalents | 20 | 61 |
| Change in cash and cash equivalents and restricted cash | (2,323) | 2,616 |
| Cash and cash equivalents and restricted cash at the beginning of the year | 4,880 | 2,264 |
| Cash and cash equivalents and restricted cash at the end of the year | 2,557 | 4,880 |
| Year Ended December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash and Cash Equivalents | 2,303 | 4,880 |
| Restricted cash | 254 | - |
| Cash and Cash Equivalents and Restricted Cash at End of the Year | 2,557 | 4,880 |
| Supplemental disclosure of non-cash financing activities: | ||
| Purchase of ShoeSizeMe – see Note 7 | 338 | - |
| Change in operating lease right-of-use asset and liability due to termination of the lease agreement | - | 181 |
| Operating lease right-of-use assets acquired through lease liability | 105 | - |
| Supplemental disclosure of Cash Flow Information: | ||
| Cash paid for interest | 14 | 41 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.